193 related articles for article (PubMed ID: 28463229)
21. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
22. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.
Pollock PM; Cohen-Solal K; Sood R; Namkoong J; Martino JJ; Koganti A; Zhu H; Robbins C; Makalowska I; Shin SS; Marin Y; Roberts KG; Yudt LM; Chen A; Cheng J; Incao A; Pinkett HW; Graham CL; Dunn K; Crespo-Carbone SM; Mackason KR; Ryan KB; Sinsimer D; Goydos J; Reuhl KR; Eckhaus M; Meltzer PS; Pavan WJ; Trent JM; Chen S
Nat Genet; 2003 May; 34(1):108-12. PubMed ID: 12704387
[TBL] [Abstract][Full Text] [Related]
23. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
Reed JA; Loganzo F; Shea CR; Walker GJ; Flores JF; Glendening JM; Bogdany JK; Shiel MJ; Haluska FG; Fountain JW
Cancer Res; 1995 Jul; 55(13):2713-8. PubMed ID: 7796391
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of human cutaneous melanoma-derived cell lines.
Ogbah Z; Puig-Butille JA; Simonetta F; Badenas C; Cervera R; Milá J; Benitez D; Malvehy J; Vilella R; Puig S
Anticancer Res; 2012 Apr; 32(4):1245-51. PubMed ID: 22493355
[TBL] [Abstract][Full Text] [Related]
25. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
26. Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma.
Guan J; Gupta R; Filipp FV
Sci Rep; 2015 Jan; 5():7857. PubMed ID: 25600636
[TBL] [Abstract][Full Text] [Related]
27. Proinvasion metastasis drivers in early-stage melanoma are oncogenes.
Scott KL; Nogueira C; Heffernan TP; van Doorn R; Dhakal S; Hanna JA; Min C; Jaskelioff M; Xiao Y; Wu CJ; Cameron LA; Perry SR; Zeid R; Feinberg T; Kim M; Vande Woude G; Granter SR; Bosenberg M; Chu GC; DePinho RA; Rimm DL; Chin L
Cancer Cell; 2011 Jul; 20(1):92-103. PubMed ID: 21741599
[TBL] [Abstract][Full Text] [Related]
28. A malignant melanoma tumor suppressor on human chromosome 11.
Robertson G; Coleman A; Lugo TG
Cancer Res; 1996 Oct; 56(19):4487-92. PubMed ID: 8813145
[TBL] [Abstract][Full Text] [Related]
29. RIP1 Kinase Is an Oncogenic Driver in Melanoma.
Liu XY; Lai F; Yan XG; Jiang CC; Guo ST; Wang CY; Croft A; Tseng HY; Wilmott JS; Scolyer RA; Jin L; Zhang XD
Cancer Res; 2015 Apr; 75(8):1736-48. PubMed ID: 25724678
[TBL] [Abstract][Full Text] [Related]
30. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.
Ohta M; Nagai H; Shimizu M; Rasio D; Berd D; Mastrangelo M; Singh AD; Shields JA; Shields CL; Croce CM
Cancer Res; 1994 Oct; 54(20):5269-72. PubMed ID: 7923152
[TBL] [Abstract][Full Text] [Related]
31. The role of microRNAs in melanoma.
Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
[TBL] [Abstract][Full Text] [Related]
32. IQGAP1 is an oncogenic target in canine melanoma.
Lee BH; Neela PH; Kent MS; Zehnder AM
PLoS One; 2017; 12(4):e0176370. PubMed ID: 28445541
[TBL] [Abstract][Full Text] [Related]
33. FES kinase promotes mast cell recruitment to mammary tumors via the stem cell factor/KIT receptor signaling axis.
Kwok E; Everingham S; Zhang S; Greer PA; Allingham JS; Craig AW
Mol Cancer Res; 2012 Jul; 10(7):881-91. PubMed ID: 22589410
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.
Marini A; Mirmohammadsadegh A; Nambiar S; Gustrau A; Ruzicka T; Hengge UR
J Invest Dermatol; 2006 Feb; 126(2):422-31. PubMed ID: 16374457
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.
Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C
Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816
[TBL] [Abstract][Full Text] [Related]
36. MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells.
Garrido C; Paco L; Romero I; Berruguilla E; Stefansky J; Collado A; Algarra I; Garrido F; Garcia-Lora AM
Carcinogenesis; 2012 Mar; 33(3):687-93. PubMed ID: 22219178
[TBL] [Abstract][Full Text] [Related]
37. The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene.
van Kempen LC; Redpath M; Elchebly M; Klein KO; Papadakis AI; Wilmott JS; Scolyer RA; Edqvist PH; Pontén F; Schadendorf D; van Rijk AF; Michiels S; Dumay A; Helbling-Leclerc A; Dessen P; Wouters J; Stass M; Greenwood CM; Ghanem GE; van den Oord J; Feunteun J; Spatz A
Sci Transl Med; 2016 Dec; 8(369):369ra177. PubMed ID: 27974665
[TBL] [Abstract][Full Text] [Related]
38. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
[TBL] [Abstract][Full Text] [Related]
39. Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.
Atkinson JM; Rank KB; Zeng Y; Capen A; Yadav V; Manro JR; Engler TA; Chedid M
PLoS One; 2015; 10(4):e0125028. PubMed ID: 25915038
[TBL] [Abstract][Full Text] [Related]
40. Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit.
Zhang Z; Zhang S; Ma P; Jing Y; Peng H; Gao WQ; Zhuang G
Carcinogenesis; 2015 Sep; 36(9):937-45. PubMed ID: 26071398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
